From Models to Medicines: Applying AI at the Right Time, with the Right Data, and the Right Teams
May 12, 2026 | 4:00–7:00 PM ET | MassBio, 700 Technology Square, Cambridge, MA
About
Join AAPS NERDG for an engaging outreach event in Cambridge, MA, featuring a panel of industry leaders at the forefront of AI-driven drug discovery. This session will explore how artificial intelligence is accelerating early discovery, enabling smarter decision-making, and transforming downstream development across modalities.
The event offers a unique opportunity to gain insights from innovators, expand your professional network, and engage in meaningful discussions on the future of pharmaceutical R&D.
The event offers a unique opportunity to gain insights from innovators, expand your professional network, and engage in meaningful discussions on the future of pharmaceutical R&D.
- Learn how AI is impacting drug discovery, design, and development workflows,
- Hear directly from industry leaders and innovators,
- Network with professionals across industry, academia, and startups,
- Explore opportunities for collaboration and career growth.
You do NOT need to be a member of AAPS or MassBio to attend.
Featured Panelists
Katya Tsaioun-Hélin (Moderator) Chief Executive Officer, Akttyva Therapeutics |
Alpha Lee Co-founder & CSO, PostEra |
Woody Sherman Chief Innovation Officer, PsiThera |
Suguna Rachakonda Vice President, BD Insilico Medicine |
Event Schedule (May 12, 2026)
4:00 PM – Registration & Networking
5:00 PM – Panel Discussion: AI-Driven Discovery in Pharma
6:00 PM – Networking Session
7:00 PM – Event Concludes
5:00 PM – Panel Discussion: AI-Driven Discovery in Pharma
6:00 PM – Networking Session
7:00 PM – Event Concludes
Location
MassBio, 700 Technology Square
Cambridge, MA 02139
Cambridge, MA 02139
